Pfizer, Gilead, GSK to lead $150 bn infectious diseases mkt by 2029: Report
Pharma giants Pfizer, Gilead Sciences, and GSK are expected to collectively generate 62 per cent of total infectious disease drug ...
Pharma giants Pfizer, Gilead Sciences, and GSK are expected to collectively generate 62 per cent of total infectious disease drug ...
